Aktie ISCO INTERNATIONAL STEM CELL CORP
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen International Stem Cell Corp OTC Bulletin Board

Aktien

ISCO

US4603781026

ISCO

Schlusskurs OTC Bulletin Board
Andere Börsenplätze
- USD - Intraday Chart für International Stem Cell Corp
28.03. International Stem Cell Corporation meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 International Stem Cell Corporation meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
International Stem Cell Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
International Stem Cell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
International Stem Cell Corporation and Dr. Andrey Semechkin Agrees to Extend (Until September 15, 2024) the Maturity Date of the Loan
Bayer says Parkinson's stem cell therapy improves symptoms in initial trial
International Stem Cell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Bayer claims early lead in Parkinson's stem cell therapy
INTERNATIONAL STEM CELL CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
International Stem Cell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
INTERNATIONAL STEM CELL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
International Stem Cell Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
International Stem Cell Corporation Auditor Raises 'Going Concern' Doubt
INTERNATIONAL STEM CELL CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
INTERNATIONAL STEM CELL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
International Stem Cell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
INTERNATIONAL STEM CELL CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
INTERNATIONAL STEM CELL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
International Stem Cell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
INTERNATIONAL STEM CELL CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
INTERNATIONAL STEM CELL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
International Stem Cell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A14QU5 Aktie
  4. ISCO Aktie
  5. Nachrichten International Stem Cell Corp
  6. Andere Sprachen